Vitrolife AB - Asset Resilience Ratio

Latest as of December 2025: 7.27%

Vitrolife AB (VITR) has an Asset Resilience Ratio of 7.27% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See VITR current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Skr809.00 Million
≈ $87.06 Million USD Cash + Short-term Investments

Total Assets

Skr11.12 Billion
≈ $1.20 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2000–2025)

This chart shows how Vitrolife AB's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Vitrolife AB's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down Vitrolife AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of Vitrolife AB's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr809.00 Million 7.27%
Short-term Investments Skr0.00 0%
Total Liquid Assets Skr809.00 Million 7.27%

Asset Resilience Insights

  • Limited Liquidity: Vitrolife AB maintains only 7.27% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Vitrolife AB Industry Peers by Asset Resilience Ratio

Compare Vitrolife AB's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 34.37%
Stratec SE
XETRA:SBS
Medical Devices 0.29%
Shinhung
KO:004080
Medical Devices 4.17%
DRTECH Corporation
KQ:214680
Medical Devices 5.18%
Novacyt
PA:ALNOV
Medical Devices 0.02%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.48%

Annual Asset Resilience Ratio for Vitrolife AB (2000–2025)

The table below shows the annual Asset Resilience Ratio data for Vitrolife AB.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 7.27% Skr809.00 Million
≈ $87.06 Million
Skr11.12 Billion
≈ $1.20 Billion
+0.77pp
2024-12-31 6.51% Skr1.14 Billion
≈ $122.14 Million
Skr17.45 Billion
≈ $1.88 Billion
+1.23pp
2023-12-31 5.27% Skr861.00 Million
≈ $92.66 Million
Skr16.33 Billion
≈ $1.76 Billion
+2.46pp
2022-12-31 2.81% Skr578.00 Million
≈ $62.20 Million
Skr20.55 Billion
≈ $2.21 Billion
-0.43pp
2021-12-31 3.24% Skr630.09 Million
≈ $67.81 Million
Skr19.43 Billion
≈ $2.09 Billion
-38.99pp
2020-12-31 42.24% Skr973.57 Million
≈ $104.77 Million
Skr2.31 Billion
≈ $248.06 Million
+42.24pp
2018-12-31 0.00% Skr-1.00K
≈ $-107.62
Skr1.70 Billion
≈ $182.67 Million
-0.08pp
2015-12-31 0.08% Skr842.00K
≈ $90.61K
Skr1.06 Billion
≈ $113.99 Million
+0.08pp
2014-12-31 0.00% Skr17.00K
≈ $1.83K
Skr972.48 Million
≈ $104.65 Million
-0.02pp
2013-12-31 0.02% Skr120.00K
≈ $12.91K
Skr487.81 Million
≈ $52.50 Million
-0.04pp
2012-12-31 0.06% Skr289.00K
≈ $31.10K
Skr462.20 Million
≈ $49.74 Million
0.00pp
2011-12-31 0.06% Skr295.00K
≈ $31.75K
Skr466.78 Million
≈ $50.23 Million
+0.04pp
2010-12-31 0.03% Skr111.00K
≈ $11.95K
Skr429.39 Million
≈ $46.21 Million
-0.02pp
2009-12-31 0.04% Skr147.00K
≈ $15.82K
Skr359.31 Million
≈ $38.67 Million
-0.01pp
2008-12-31 0.05% Skr180.00K
≈ $19.37K
Skr342.66 Million
≈ $36.88 Million
-0.01pp
2007-12-31 0.06% Skr183.00K
≈ $19.69K
Skr299.46 Million
≈ $32.23 Million
-10.68pp
2004-12-31 10.74% Skr19.93 Million
≈ $2.15 Million
Skr185.54 Million
≈ $19.97 Million
-11.74pp
2001-12-31 22.49% Skr73.77 Million
≈ $7.94 Million
Skr328.04 Million
≈ $35.30 Million
-5.98pp
2000-12-31 28.46% Skr49.30 Million
≈ $5.31 Million
Skr173.22 Million
≈ $18.64 Million
--
pp = percentage points

About Vitrolife AB

ST:VITR Sweden Medical Devices
Market Cap
$1.33 Billion
Skr12.39 Billion SEK
Market Cap Rank
#7731 Global
#116 in Sweden
Share Price
Skr91.50
Change (1 day)
-0.33%
52-Week Range
Skr85.20 - Skr151.10
All Time High
Skr560.50
About

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware … Read more